International Clinical Trial: A Single-Center Prospective Randomized Controlled Clinical Study Evaluating the Efficacy of High-Dose Dexamethasone Followed by Sequential Prednisone Maintenance Therapy in Adults with Newly Diagnosed Immune Thrombocytopenia

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117105) titled 'A Single-Center Prospective Randomized Controlled Clinical Study Evaluating the Efficacy of High-Dose Dexamethasone Followed by Sequential Prednisone Maintenance Therapy in Adults with Newly Diagnosed Immune Thrombocytopenia' on Jan. 20.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Nanjing Drum Tower Hospital

Condition: Immune Thrombocytopenia (ITP)

Intervention: Maintenance therapy with prednisone following HD-DXM (HD-DXM-P):1. Phase 1 (Days 1-4): Dexamethasone intravenous infusion, 40 mg/day x 4 days 2. Phase 2 (from Day 5 onward): Prednisone oral administration, 0.5 mg/kg/day,...